Company Focus

Regeneron Pharmaceuticals Inc

Latest Regeneron Pharmaceuticals Inc News



Latest News & Features of interest to Regeneron Pharmaceuticals Inc

Latest In Brief for Regeneron Pharmaceuticals Inc

Biotechnology
The Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico has approved humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody Leqembi (lecanemab) for the treatment of early Alzheimer’s disease (AD).   5 December 2024

Latest Relevant Ones To Watch News

Relevant Ones to Watch Companies

Reset all filters
Refine Search